{
    "medicine_id": "b7249c4e2420ea11dd67eecb837c79f2dc87fe2f",
    "platform_id": "DB09208",
    "metadata": {
        "name": "Krystexxa 8 mg ml Injection solution concentrate",
        "composition": "8 mg ml Pegloticase",
        "clinical_particulars": {
            "therapeutic_indications": "For the treatment of chronic gout in adult patients refractory to conventional therapy",
            "contraindications": {
                "disease": "Conditions that should be monitored for when starting treatment with pegloticase include anaphylaxis infusion reactions an increase in gout flares and or an exacerbation of pre existing congestive heart failure",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "NA",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB04854",
                        "description": "The risk or severity of adverse effects can be increased when Febuxostat is combined with Pegloticase"
                    },
                    {
                        "drugbank-id": "DB00008",
                        "description": "The therapeutic efficacy of Pegloticase can be decreased when used in combination with Peginterferon alfa 2a"
                    },
                    {
                        "drugbank-id": "DB00019",
                        "description": "The therapeutic efficacy of Pegloticase can be decreased when used in combination with Pegfilgrastim"
                    },
                    {
                        "drugbank-id": "DB00022",
                        "description": "The therapeutic efficacy of Pegloticase can be decreased when used in combination with Peginterferon alfa 2b"
                    },
                    {
                        "drugbank-id": "DB00059",
                        "description": "The therapeutic efficacy of Pegloticase can be decreased when used in combination with Pegaspargase"
                    },
                    {
                        "drugbank-id": "DB00061",
                        "description": "The therapeutic efficacy of Pegloticase can be decreased when used in combination with Pegademase"
                    },
                    {
                        "drugbank-id": "DB00082",
                        "description": "The therapeutic efficacy of Pegloticase can be decreased when used in combination with Pegvisomant"
                    },
                    {
                        "drugbank-id": "DB01839",
                        "description": "The therapeutic efficacy of Pegloticase can be decreased when used in combination with Propylene glycol"
                    },
                    {
                        "drugbank-id": "DB03394",
                        "description": "The therapeutic efficacy of Pegloticase can be decreased when used in combination with Heptaethylene glycol"
                    },
                    {
                        "drugbank-id": "DB04895",
                        "description": "The therapeutic efficacy of Pegloticase can be decreased when used in combination with Pegaptanib"
                    },
                    {
                        "drugbank-id": "DB05202",
                        "description": "The therapeutic efficacy of Pegloticase can be decreased when used in combination with Egaptivon pegol"
                    },
                    {
                        "drugbank-id": "DB05321",
                        "description": "The therapeutic efficacy of Pegloticase can be decreased when used in combination with PEG uricase"
                    },
                    {
                        "drugbank-id": "DB05860",
                        "description": "The therapeutic efficacy of Pegloticase can be decreased when used in combination with Peginterferon alfacon 1"
                    },
                    {
                        "drugbank-id": "DB06022",
                        "description": "The therapeutic efficacy of Pegloticase can be decreased when used in combination with GlycoPEG GCSF"
                    },
                    {
                        "drugbank-id": "DB06293",
                        "description": "The therapeutic efficacy of Pegloticase can be decreased when used in combination with Pegnivacogin"
                    },
                    {
                        "drugbank-id": "DB06325",
                        "description": "The therapeutic efficacy of Pegloticase can be decreased when used in combination with Pegpleranib"
                    },
                    {
                        "drugbank-id": "DB06611",
                        "description": "The therapeutic efficacy of Pegloticase can be decreased when used in combination with Pegsunercept"
                    },
                    {
                        "drugbank-id": "DB06811",
                        "description": "The therapeutic efficacy of Pegloticase can be decreased when used in combination with Polidocanol"
                    },
                    {
                        "drugbank-id": "DB08894",
                        "description": "The therapeutic efficacy of Pegloticase can be decreased when used in combination with Peginesatide"
                    },
                    {
                        "drugbank-id": "DB08904",
                        "description": "The therapeutic efficacy of Pegloticase can be decreased when used in combination with Certolizumab pegol"
                    },
                    {
                        "drugbank-id": "DB09107",
                        "description": "The therapeutic efficacy of Pegloticase can be decreased when used in combination with Methoxy polyethylene glycol epoetin beta"
                    },
                    {
                        "drugbank-id": "DB09122",
                        "description": "The therapeutic efficacy of Pegloticase can be decreased when used in combination with Peginterferon beta 1a"
                    },
                    {
                        "drugbank-id": "DB09287",
                        "description": "The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Pegloticase"
                    },
                    {
                        "drugbank-id": "DB09329",
                        "description": "The therapeutic efficacy of Antihemophilic Factor Recombinant PEGylated can be decreased when used in combination with Pegloticase"
                    },
                    {
                        "drugbank-id": "DB11077",
                        "description": "The therapeutic efficacy of Polyethylene glycol 400 can be decreased when used in combination with Pegloticase"
                    },
                    {
                        "drugbank-id": "DB11567",
                        "description": "The therapeutic efficacy of Insulin peglispro can be decreased when used in combination with Pegloticase"
                    },
                    {
                        "drugbank-id": "DB11661",
                        "description": "The therapeutic efficacy of Eptacog alfa pegol activated can be decreased when used in combination with Pegloticase"
                    },
                    {
                        "drugbank-id": "DB11707",
                        "description": "The therapeutic efficacy of Olaptesed Pegol can be decreased when used in combination with Pegloticase"
                    },
                    {
                        "drugbank-id": "DB12258",
                        "description": "The therapeutic efficacy of Abicipar Pegol can be decreased when used in combination with Pegloticase"
                    },
                    {
                        "drugbank-id": "DB12578",
                        "description": "The therapeutic efficacy of Lexaptepid Pegol can be decreased when used in combination with Pegloticase"
                    },
                    {
                        "drugbank-id": "DB12814",
                        "description": "The therapeutic efficacy of Cepeginterferon alfa 2B can be decreased when used in combination with Pegloticase"
                    },
                    {
                        "drugbank-id": "DB12839",
                        "description": "The therapeutic efficacy of Pegvaliase can be decreased when used in combination with Pegloticase"
                    },
                    {
                        "drugbank-id": "DB12842",
                        "description": "The therapeutic efficacy of Pegamotecan can be decreased when used in combination with Pegloticase"
                    },
                    {
                        "drugbank-id": "DB13200",
                        "description": "The therapeutic efficacy of Lipegfilgrastim can be decreased when used in combination with Pegloticase"
                    },
                    {
                        "drugbank-id": "DB13933",
                        "description": "The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Pegloticase"
                    },
                    {
                        "drugbank-id": "DB14700",
                        "description": "The therapeutic efficacy of Damoctocog alfa pegol can be decreased when used in combination with Pegloticase"
                    },
                    {
                        "drugbank-id": "DB14712",
                        "description": "The therapeutic efficacy of Elapegademase can be decreased when used in combination with Pegloticase"
                    },
                    {
                        "drugbank-id": "DB00437",
                        "description": "The risk or severity of adverse effects can be increased when Allopurinol is combined with Pegloticase"
                    },
                    {
                        "drugbank-id": "DB01032",
                        "description": "The risk or severity of adverse effects can be increased when Probenecid is combined with Pegloticase"
                    },
                    {
                        "drugbank-id": "DB01138",
                        "description": "The risk or severity of adverse effects can be increased when Sulfinpyrazone is combined with Pegloticase"
                    },
                    {
                        "drugbank-id": "DB04831",
                        "description": "The risk or severity of adverse effects can be increased when Tienilic acid is combined with Pegloticase"
                    },
                    {
                        "drugbank-id": "DB07402",
                        "description": "The risk or severity of adverse effects can be increased when Azapropazone is combined with Pegloticase"
                    },
                    {
                        "drugbank-id": "DB11560",
                        "description": "The risk or severity of adverse effects can be increased when Lesinurad is combined with Pegloticase"
                    },
                    {
                        "drugbank-id": "DB12319",
                        "description": "The risk or severity of adverse effects can be increased when Benzbromarone is combined with Pegloticase"
                    },
                    {
                        "drugbank-id": "DB13277",
                        "description": "The risk or severity of adverse effects can be increased when Benziodarone is combined with Pegloticase"
                    },
                    {
                        "drugbank-id": "DB00232",
                        "description": "The therapeutic efficacy of Pegloticase can be decreased when used in combination with Methyclothiazide"
                    },
                    {
                        "drugbank-id": "DB00436",
                        "description": "The therapeutic efficacy of Pegloticase can be decreased when used in combination with Bendroflumethiazide"
                    },
                    {
                        "drugbank-id": "DB00562",
                        "description": "The therapeutic efficacy of Pegloticase can be decreased when used in combination with Benzthiazide"
                    },
                    {
                        "drugbank-id": "DB00606",
                        "description": "The therapeutic efficacy of Pegloticase can be decreased when used in combination with Cyclothiazide"
                    },
                    {
                        "drugbank-id": "DB00774",
                        "description": "The therapeutic efficacy of Pegloticase can be decreased when used in combination with Hydroflumethiazide"
                    },
                    {
                        "drugbank-id": "DB00880",
                        "description": "The therapeutic efficacy of Pegloticase can be decreased when used in combination with Chlorothiazide"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "The therapeutic efficacy of Pegloticase can be decreased when used in combination with Hydrochlorothiazide"
                    },
                    {
                        "drugbank-id": "DB01021",
                        "description": "The therapeutic efficacy of Pegloticase can be decreased when used in combination with Trichlormethiazide"
                    },
                    {
                        "drugbank-id": "DB01324",
                        "description": "The therapeutic efficacy of Pegloticase can be decreased when used in combination with Polythiazide"
                    },
                    {
                        "drugbank-id": "DB13430",
                        "description": "The therapeutic efficacy of Pegloticase can be decreased when used in combination with Mebutizide"
                    },
                    {
                        "drugbank-id": "DB13532",
                        "description": "The therapeutic efficacy of Pegloticase can be decreased when used in combination with Cyclopenthiazide"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}